<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJOC</journal-id><journal-title-group><journal-title>International Journal of Organic Chemistry</journal-title></journal-title-group><issn pub-type="epub">2161-4687</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijoc.2018.84027</article-id><article-id pub-id-type="publisher-id">IJOC-89019</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Synthesis of New Fluorinated Amino-Heterocyclic Compounds Bearing 6-Aryl-5-Oxo-1,2,4-Triazin-3-Yl Moiety as Antimicrobial Agents
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wafa</surname><given-names>A. Bawazir</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Reda</surname><given-names>M. Abdel-Rahman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Chemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia</addr-line></aff><pub-date pub-type="epub"><day>24</day><month>10</month><year>2018</year></pub-date><volume>08</volume><issue>04</issue><fpage>349</fpage><lpage>358</lpage><history><date date-type="received"><day>23,</day>	<month>September</month>	<year>2018</year></date><date date-type="rev-recd"><day>4,</day>	<month>December</month>	<year>2018</year>	</date><date date-type="accepted"><day>7,</day>	<month>December</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Some more new fluorine substitutedamino compounds bearing 6-aryl-5-oxo-1,2,4-triazin-3-yl moieties and its derivatives 
  3 - 
  7 have been synthesised successfully from aroylation of 6-(2’-aminophenyl)-3-thioxo-1,2,4-triazin-5-one (
  1), followed by fluoro amination with 4-fluoroanilinein Abs EtOH and then treated with ammonia/EtOH and finally acylation/aroylation or cyclocondensation reactions with malonic acid in AcOH. Structure of the products has been established upon elemental analysis and their spectral measurements. All the obtained compounds evaluated as antimicrobial agents were the compounds which contained both nitro and fluorine elements and exhibited a highly activity the other derivatives.
 
</p></abstract><kwd-group><kwd>Facile Synthesis</kwd><kwd> Fluoro-Amino-1</kwd><kwd>2</kwd><kwd>4-Triazines</kwd><kwd> Antimicrobials</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Fluorine substituted 6-(2’-aminophenyl)-3-thioxo-1,2,4-triazin-5-one derivatives exhibit a wide spectrum of the medicinal, pharmacological and biological fields such as anti-HIV [<xref ref-type="bibr" rid="scirp.89019-ref1">1</xref>] , anti-cancer [<xref ref-type="bibr" rid="scirp.89019-ref2">2</xref>] , and antimicrobial [<xref ref-type="bibr" rid="scirp.89019-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89019-ref4">4</xref>] activity. On the other hand, fluorinated 6-aryl-3,5-diamino-1,2,4-triazines is used as lamotrigine drugs especially as ati-inflammatory agents [<xref ref-type="bibr" rid="scirp.89019-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.89019-ref6">6</xref>] . In addition, introduction fluorine atoms to functionally 1,2,4-triazines often improve and enhance that physical, chemical and biological properties [<xref ref-type="bibr" rid="scirp.89019-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89019-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.89019-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.89019-ref10">10</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Based upon these observations and in view of our previous work [<xref ref-type="bibr" rid="scirp.89019-ref6">6</xref>] the objective of this work is to</p><p>study the chemical reactivity of polyfunctional 1,2,4-triazinone used for synthetic of lamotrigine analogues drugs in view of their antimicrobial activity.</p></sec><sec id="s2"><title>2. Chemistry</title><p>In the recent years, numerous small molecule containing a polyfunctional 1,2,4-triazine scaffold have been shown to exhibit an important properties as pharmacological, medicinal and biological effects [<xref ref-type="bibr" rid="scirp.89019-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.89019-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.89019-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.89019-ref14">14</xref>] . In search for new fluorine compounds exhibit a highly biocidal effects, the present work tends to synthesis some new fluorine substituted 3-amino-1,2,4-triazines as Lamotrigine drug analogues. Therefore, aroylation of 6-(2’-aminophenyl-3-thioxo-1,2,4-triazin-5-(2H, 4H) one (1) by warm with 4-nitrobenzoyl chloride and/or 4-methoxy benzoyl chloride in DMF afforded 6-[2’-(4’’-substituted aroyl)aminophenyl]-3-thioxo-1,2,4-triazin-5(2H, 4H) ones (2a, b) (Scheme 1).</p><p>Fluoroamination of compounds 2a, b via reflux with 4-fluoroaniline in EtOH via loss of H<sub>2</sub>S, yielded 3-(4’-fluorophenyl)amino-6-aryl-1,2,4-triazin-5(4H)ones (3a, b).</p><p>On the other hand, reflux of compounds 3 with ammonia in EtOH, furnished 5-amino-3-(4’fluorophenylamino)-6-aryl-1,2,4-triazines (4a, b) respectively as fluorinated Lamotriagine analogues drugs (Scheme 1). Reactivity of a free amino group at position 5 of 1,2,4-triazines 4 deduced from addition of phenyl isothiocyanate under reflux with DMF to produce N,N-disubstituted thioureas 5 the ring closure reaction with malonic acid in boil with glacial AcOH, afforded N’,N<sup>3</sup>-disubstituted-thiobarbituric acid 6. Finally, heterocyclization of compounds 3a, b via boiling with DMF via dehydration furnished 3-(4’-fluorophenyl)amino-5-(aroyl-1,2,4-triazino[5,6-b]indoles (7a, b) (Scheme 1).</p><disp-formula id="scirp.89019-formula420"><graphic  xlink:href="//html.scirp.org/file/3-1020646x3.png"  xlink:type="simple"/></disp-formula><p>Scheme 1. Synthesis some new fluorine substituted 3-amino-1,2,4-triazines as Lamotrigine drug analogues.</p></sec><sec id="s3"><title>3. Results and Discussion</title><p>The structures of the new produced fluorinated systems 3 - 7 have been deduced from both the correct elemental analysis and their spectral spectrum. IR spectra of both 2a &amp; 2b recovered the disappearance of NH<sub>2</sub> group, with an additional new carbonyl of benzamide group at 1620 cm<sup>−1</sup>, in addition the presence of the characteristic bands at ν 1530 &amp; 1350 for asymmetric and symmetric NO<sub>2</sub> group of 2a and ν at 1050 cm<sup>−1</sup> for the ether group -O-Me of 2b, which deduce that structure.</p><p>On the other hand, IR absorption spectra of 4a &amp; 4b showed the presence of ν at 3350, 3150 &amp; 1610 cm<sup>−1</sup>, for NH<sub>2</sub>, NH and CONH functional groups, in addition of ν at 1240 - 1230 cm<sup>−1</sup> for C-F groups, with lacks of SH functional group.</p><p>IR spectra of compounds 5a &amp; 5b showed the presence of two ν at 3200 - 3150, 1610, 1250 cm<sup>−1</sup> for two NH, CONH and C-F functional groups.</p><p>Also, IR spectra of 6a, 6b recorded the ν at 3150 - 3090 cm<sup>−1</sup> for NH and 1610 - 1600 for CONH, with ν at 1240 cm<sup>−1</sup> for C-F, in addition ν at 1520, 1350 cm<sup>−1</sup> for asymmetric NO<sub>2</sub> for 6a with ν at 1080 cm<sup>−1</sup> for the ethereal group -C-O-Me. Compounds 6 showed ν at 1340 cm<sup>−1</sup> for acyclic NCSN with ν at 2900, 2880, 1480, 1440 cm<sup>−1</sup> for cyclic CH<sub>2</sub> group.</p><p>IR absorption spectra of compounds 7 showed only ν at 3100, 1700, 1250 cm<sup>−1</sup> for NH, C=O &amp; C-F functional groups which confirm that structures.</p><p><sup>1</sup>HNMR spectra of compounds 3 - 7 showed the resonated signals at 12 - 11 ppm for NH protons with the d d signals at 7.2 &amp; 7.1 ppm for CH adjacent of fluorine atoms, with other aromatic protons at 7 - 6.6 ppm. Only the compounds 2a-6b showed resonated signals at δ 3.5 ppm for OMe proton present. In addition, spectra of 7a, 7b exhibited only δ at 11.0 ppm for NH proton.</p><p><sup>13</sup>Cnmr spectra of the new compounds showed mainly (3, 4, 6 &amp; 7) the resonated signals at δ 160 - 155 ppm for C=O, and δ at 145 ppm for C-F, in addition δ at 140 ppm for C=N, with a signals at δ 130 - 120 ppm for aromatic carbons.</p><p>Compounds 5b, 6b exhibited δ at 24 ppm for CH<sub>3</sub>O carbons. Mass fragmentation patterns of compound 4 showed that a molecular ion peak with a base peak at m/z 95 attribute to 4-fluorophenyl fragment (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Only the <sup>13</sup>Cnmr of 6 recorded δ at 180, 160, 150 ppm attribute to C=S, C=O of thiobarbituric acid with δ at 40 ppm for OMe carbon.</p></sec><sec id="s4"><title>4. Experimental</title><p>Melting points determined with an electrochermal Bibly Stuart Scientific melting point sample (UK). A Perkin Elmer Model PXI-FT system 55529 was used for recording IR spectra of the prepared compounds. A Brurker advance DPX 400 MHz model uses TMS as internal standard was used for recording the 1H and 13C NMR spectra of the compounds on deuterated DMSO-d6. A GC-MS-GP 1000 Ex model is used for recording the mass spectra of the compounds. Electronic spectra recorded in ethanol on Shimadzu uv and visible 310 IPC Spectrophotometer. Elemental analysis was performed in micro analytical center of Cairo University, Cairo, Egypt. Compound 1 obtained by the reported method [<xref ref-type="bibr" rid="scirp.89019-ref1">1</xref>] . Biological activity carried out in Biology center, Faculty of Science, AinShams University.</p><p>6-(2’-Aroylamino)phenyl-3-thioxo-1,2,4-triazin-5-(2H,4H)ones (2a &amp; 2b)</p><p>A mixture of 1 [<xref ref-type="bibr" rid="scirp.89019-ref1">1</xref>] (0.01 mol) and 4-nitrobenzoyl chloride or 4-methyl benzoyl chloride (0.01 mol) in DMF (20 mL) refluxed for 30 min., cooled and poured onto ice. The obtained solid filtered off and crystallized from EtOH to give 2a or 2b respectively.</p><p>2a: 68%, m.p. 248˚C - 250˚C. IR (Cm<sup>−1</sup>) 2a, 3200 (NH), 1680, 1620 (CO, CONH), 1530 &amp; 1350 (asymmetric &amp; symmetric NO<sub>2</sub>), 1200 (C=S), 880 (substituted phenyl). <sup>1</sup>HNMR (DMSO-d<sub>6</sub>) (δ) ppm.: 11.8 (s, 1H, NH), 8.5 (s, 1H, NHCO), 7.7 - 7.2 (m, 4H, aromatic protons), 5.5 (s, 1H, SH). <sup>13</sup>Cnmr (DMSO-d<sub>6</sub>) (δ) ppm: 179 (C=S), 165 (C=O), 155 (CONH), 140 (C=N), 130 - 120 (aromatic carbons). Analytical data Calcd: C, 52.03; H, 2.98; N, 18.97; S, 8.67% for C<sub>16</sub>H<sub>11</sub>N<sub>5</sub>O<sub>4</sub>S (369). Found: C, 51.88; H, 2.80; N, 18.77; S, 8.55%.</p><p>2b: 88%, m.p. 232˚C - 235˚C. IR (ν Cm<sup>−1</sup>) 3180 (NH of 1,2,4-triazin), 2900 - 2880 (str. CH<sub>3</sub>), 1670, 1610 (C=O, CONH), 1580 (C=N), 1480, 1440 (bending CH<sub>3</sub>), 1180 (C=S), 820 (aromatic CH). 1 HNMR (DMSO-d<sub>6</sub>) (δ) ppm.: 11.8, 10.8, 8.9 (each s, 3 NH), 7.6 - 7.2 (m, 4H, aromatic protons), 1.25 (s, 3H, CH<sub>3</sub>). 13 Cnmr (DMSO-d<sub>6</sub>) (δ) ppm: 180 (C=S), 166 (C=O), 158 (CONH), 142 (C=N), 132 - 122 (aromatic CH), 44 (CH<sub>3</sub>-O). Analytical data Calcd: C, 57.79; H, 3.68; N, 15.86; S, 9.06% for C<sub>17</sub>H<sub>13</sub>N<sub>4</sub>OS (353). Found: C, 57.59; H, 3.60; N, 15.66; S, 8.59%.</p><p>6-(2’-Aroylamino)phenyl-3-(4’-fluorophenyl)amino-1,2,4-triazin-5-(2H)ones(3a &amp; 3b)</p><p>A mixture of 2a or 2b (0.01 mol) with 4-fluoroaniline (0.01 mol) in EtOH (50 mL) in reflux for 6 h, cooled. The produced solid filtered off and crystallized from EtOH to give 3a &amp; 3b respectively.</p><p>3a: 66%, m.p 350˚C. IR (ν Cm<sup>−1</sup>: 3200 - 3100 (NH, NH), 1680, 1600 (C=O, CONH), 1530, 1350 (asymmetric &amp; symmetric NO<sub>2</sub>), 1250 (C-F), 900, 820 (substituted phenyl), 750 (C-F). <sup>1</sup>HNMR (DMSO-d6) (δ) ppm.: 11.6, (s, 1H, NH), 10.5 (s, 1H, NHCO), 7.8 - 7.6, 7.4 - 7.25 (each m, 8H, aromatic protons), 7.1 - 6.9, 6.6 - 6.5 (dd, CH, adjacent to C-F). <sup>13</sup>Cnmr (DMSO-d<sub>6</sub>) (δ) ppm: 160, 152 (C=O, CONH), 145 (C-F), 140 (C=N), 130 - 122 (aromatic carbons). Analytical data Calcd: C, 59.19; H, 3.36; N, 18.83; F, 4.26% for C<sub>22</sub>H<sub>15</sub>N<sub>6</sub>O<sub>4</sub>F (446). Found: C, 58.88; H, 3.15; N, 18.65; F, 4.08%.</p><p>3b: yield 82%, m.p 250˚C - 252˚C. IR (ν Cm<sup>−1</sup>: 3150 (NH), 3050 (aromatic CH), 2950, 2880 (aliphatic CH), 1680, 1620 (C=O, CONH), 1580 (C=N), 1480 (deformation CH<sub>3</sub>), 1240 (C-F), 1080 (C-O-C), 880, 820 (substituted phenyl), 720 (C-F). <sup>1</sup>HNMR (DMSO-d<sub>6</sub>) (δ) ppm.: 11.8, 10.8 (each s, 3H, 3NH), 7.8 - 7.2 (m, 8H, aromatic protons), 7.0 - 6.8 (d,d, CH, adjacent to C-F), 1.2 (s, 3H, CH3). <sup>13</sup>Cnmr (DMSO-d<sub>6</sub>) (δ) ppm: 160, 150 (C=O), 145 (C-F), 140 (C=N), 130 - 122 (aromatic carbons), 44 (CH3). Analytical data Calcd: C, 64.03; H, 4.17; N, 16.24; F, 4.40% for C<sub>23</sub>H<sub>18</sub>N<sub>5</sub>O<sub>3</sub>F (431). Found: C, 63.85; H, 4.01; N, 16.12; F 4.25%.</p><p>5-Amino-3-(4’-fluorophenyl)amino-6-(2’-aroylamino)-phenyl-1,2,4-triazins (4a &amp; 4b)</p><p>A mixture of 3a or 3b (5.0 gm and liquid ammonia 20.0 mL) in EtOH (20 mL) in reflux for 3 h, cooled then drops of acetic acid were added. The resultant solid filtered off and crystallized from MeOH to give 4a &amp; 4b respectively.</p><p>4a: 55%, m.p &gt; 300˚C. IR (ν Cm<sup>−1</sup>: 3400 - 3100 (b, NH, NH<sub>2</sub>), 3050 (aromatic CH), 1640 (deformation NH<sub>2</sub>), 1620 (CONH), 1580 (C=N), 1520, 1350 (asymmetric &amp; symmetric NO<sub>2</sub>), 1240 (C-F), 880, 820 (substituted phenyl), 780 (C-F). <sup>1</sup>HNMR (DMSO-d<sub>6</sub>) (δ) ppm.: 11.6, 10.80 (each s, 2H, 2NH), 7.9 - 7.6 (m, 4H, aromatic protons), 7.3, 7.1 (d, d, 2H, CH, adjacent to C-F), 3.66 (s, 2H, NH<sub>2</sub>). 13 Cnmr (DMSO-d<sub>6</sub>) (δ) ppm: 155 (CONH), 145 (C-F), 142 (C=N), 140, 138 (C-N of 1,2,4-triazine), 130 - 120 (aromatic carbons). M/S (Int.%): 445 (447, M + 2, 10.15%); 183 (36.1); 155 (81.1); 136 (8.5), 116 (11.1) &amp; 95 (100%). Analytical data Calcd: C, 59.32; H, 3.59; N, 22.02; F, 4.26% for C<sub>22</sub>H<sub>16</sub>N<sub>7</sub>O<sub>3</sub>F (445). Found: C, 59.11; H, 3.25; N, 21.88; F, 4.15%.</p><p>4b: yield 68%, m.p 260˚C - 262˚C. IR (ν Cm<sup>−1</sup>): 3300 - 3100 (b, NH, NH<sub>2</sub>), 3050 (aromatic CH), 1640, 1610 (CONH), 1580, 1560 (C=N), 1530, 1320 (asymmetric &amp;symmetric NO<sub>2</sub>), 910, 840 (substituted phenyl), 750 (C-F).). <sup>1</sup>HNMR (DMSO-d<sub>6</sub>) (δ) ppm.: 12.0, 10.8 (each s, 2H, 2NH), 7.7 - 7.2 (m, 4H, aromatic protons), 7.0 - 6.7 (dd, CH, adjacent to C-F), 3.4 (s, 2H, NH<sub>2</sub>). <sup>13</sup>Cnmr (DMSO-d<sub>6</sub>) (δ) ppm: 155 (CONH), 145 (C-F), 145 (C-F), 142 (C=N), 138, 136 (C-N) 130 - 120 (aromatic carbons). Analytical data Calcd: C, 64.33; H, 4.19; N, 19.58% for C<sub>23</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub>F (429). Found: C, 64.01; H, 4.00; N, 19.39; F 4.11%.</p><p>N-(Phenyl)-N2-[3-(4’-fluorophenyl)amino-6-(aroylamino)-phenyl-1,2,4-triazin-3’-yl]thiourea (5a &amp; 5b)</p><p>A mixture of 4a or 4b (0.01 mol) and phenylisothiocyanate (0.01 mol) in DMF (20 mL) in reflux for 2 h, cooled. The yielded solid filtered off and crystallized from EtOH to give 5a &amp; 5b respectively.</p><p>5a: 60%, m.p 313˚C - 315˚C. IR (ν Cm<sup>−1</sup>: 3200, 3150, 3100 (NH), 3050 (aromatic CH), 1610 (CONH), 1530, 1330 (asymmetric &amp; symmetric NO<sub>2</sub>), 1350 (NCSN), 1240 (C-F), 1188 (C=S), 910, 880, 820 (substituted phenyl), 720 (C-F). Analytical data Calcd: C, 59.38; H, 4.60; N, 19.11; F, 3.24; S, 5.46% for C<sub>29</sub>H<sub>27</sub>N<sub>8</sub>O<sub>3</sub>FS (586). Found: C, 5.11; H, 4.35; N, 19.01; F, 3.05; S, 5.30%.</p><p>5b: yield 70%, m.p 325˚C - 327˚C. IR (ν Cm<sup>−1</sup>: 3300, 3210, 3180 (NH), 3060 (aromatic CH), 2900 (aliphatic CH), 1620 (CONH), 1570 (C=N), 1350 (NCSN), 1190 (C=S), 1050 (C-O-C), 920, 870, 820 (substituted phenyl), 720 (C-F). Analytical data Calcd: C, 63.15; H, 5.08; N, 17.19, F, 3.33; S, 5.61% for C<sub>30</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>FS (570). Found: C, 62.85; H, 4.79; N, 17.01; F 3.10; S, 6.36%.</p><p>N’-(Phenyl)-N3-[3-(4’-fluorophenyl)amino-6-(2-aroylamino)-phenyl-1,2,4-triazin-5’-yl]thiobarbituric acids (6a &amp; 6b)</p><p>A mixture of 5a or 5b (0.01 mol) and malonic acid (0.01 mol) in glacial acetic acid (20 mL) in reflux for 4 h, cooled. The obtained solid filtered off and crystallized from EtOH to give 6a &amp; 6b respectively.</p><p>6a: 55%, m.p 338˚C - 340˚C. IR (ν Cm<sup>−1</sup>: 3300, 3150 (2NH), 3060 (aromatic CH), 2950, 2880 (aliphatic CH), 1660, 1650, 1610 (3C=0), 1600 &amp; 1580 (C=N), 1480, 1440 (deformation CH<sub>2</sub>), 1530, 1340 (asymmetric &amp; symmetric NO<sub>2</sub>), 1240 (C-F), 1188 (C=S), 950, 910, 880, 820 (substituted phenyl), 750 (C-F). Analytical data Calcd: C, 59.16; H, 3.38; N, 17.25; S, 4.93; F, 2.92% for C<sub>32</sub>H<sub>22</sub>N<sub>8</sub>SFO<sub>5</sub> (649). Found: C, 58.89; H, 3.15; N, 17.11; S, 4.80; F, 2.88%.</p><p>6b: 78%, m.p 325˚C - 327˚C. IR (ν Cm<sup>−1</sup>): 3280, 3210, 3150 (NH), 3080 (aromatic CH), 2960, 2880 (aliphatic CH), 1670, 1660, 1600 (3C=O), 1580 (C=N), 1330 (cyclic NCSN), 1250 (C-F), 1188 (C=S), 1100 (C-O-C), 920, 880, 820 (substituted phenyl), 720 (C-F). <sup>1</sup>HNMR (DMSO-d<sub>6</sub>) (δ) ppm.: 12.0, 10.0, 8.5 (each s, 3NH), 7.6 - 7.4, 7.1 - 6.8, 6.6 - 6.35 (each m, 17H, aromatic protons), 4.8 - 4.66 (s, 2H, CH<sub>2</sub>), 3.5 - 3.25(s, 3H, CH<sub>3</sub>). <sup>13</sup>Cnmr (DMSO-d<sub>6</sub>) (δ) ppm: 188 (C=S), 130 - 120 (aromatic carbons), 44 (CH<sub>3</sub>). Analytical data Calcd: C, 64.8; H, 3.88; N, 15.88; S, 5.18; F, 3.07% For C<sub>33</sub>H<sub>24</sub>N<sub>7</sub>SFO<sub>3</sub> (617). Found C, 63.95; H, 3.59; N, 15.60; S 5.10; F, 2.85% .</p><p>3-(4’-fluorophenyl)amino-5-aroyl-1,2,4-triazino[5,6-b]indoles (7a &amp; 7b)</p><p>Compound 3a or 3b (0.5 gm) with DMF (20 mL) reflux for 2 h, cooled then poured onto ice. The produced solid filtered off and crystallized from MeOH to give 7a &amp; 7b respectively.</p><p>7a: 60%, m.p 328˚C - 330˚C. IR (ν Cm<sup>−1</sup>: 3100 (NH), 3050 (aromatic CH), 1700, 1580 (C=N), 1530, 1340 (asymmetric &amp; symmetric NO<sub>2</sub>), 1240 (C-F), 890, 860, 810 (substituted phenyl). Analytical data Calcd: C, 63.04; H, 4.52; N, 20.28; F, 3.44% for C<sub>22</sub>H<sub>10</sub>N<sub>6</sub>FO<sub>3</sub> (426). Found: C, 62.89; H, 4.18; N, 20.15; F, 3.18%. M/S (Int.%): 553 (M + 1, 5.5), 163 (1.15), 129 (88), 112 (13), 95 (100), 88 (5.11).</p><p>7b: 72%, m.p 268˚C - 270˚C. IR (ν Cm<sup>−1</sup>: 3180 (NH), 3060 (aromatic CH), 2960, 2888 (aliphatic CH), 1690 (C=O), 1580 (C=N), 1250 (C-F), 1090 (C-O-C), 890, 840, 810 (substituted phenyl), 750 (C-F). Analytical data Calcd: C, 67.16; H, 5.03; N, 18.2; F, 3.54% For C<sub>23</sub>H<sub>14</sub>N<sub>5</sub>FO<sub>2</sub> (411). Found C, 66.89; H, 4.90; N, 18.15; F, 3.25% .</p></sec><sec id="s5"><title>5. The Antimicrobial Evaluation</title><p>The new fluorinated 1,2,4-triazinones 3-7 were evaluated as antimicrobial agents by the use of agar well diffusion method [<xref ref-type="bibr" rid="scirp.89019-ref14">14</xref>] against Escherichia Coli as bacteria and against Penicillium Chrysogemuum as fungi. The Penicillin (25 μg/ mL) and mystatin (25 μg/ mL) used as antibiotic reference. DMSO (1%) also used as a control. The zones of inhibition measured in mm. The results reported in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>From the results obtained we can obtained that:</p><p>1) All the tested compounds showed the microbial activity which contain -OMe group (2-7b derivatives), showed higher activity than that contains the NO<sub>2 </sub>group (a derivatives).</p><p>2) The reduced growth activity against E. coli and or P. chrysogenum exhibit by the synthesized fluorinated 1,2,4-triazins as:</p><p>4b &gt; 3b &gt; 4a &gt; 3a; 5b &gt; 5a &gt; 7b &gt; 7a and 6b &gt; 6a.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The antimicrobial activity of the New Fluorinated Systems</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Comp.</th><th align="center" valign="middle" >Bacteria</th><th align="center" valign="middle" >Fungi</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >Growth Reduction Zone in mm</td></tr><tr><td align="center" valign="middle" >3a</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >Rd</td></tr><tr><td align="center" valign="middle" >3b</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >Rd</td></tr><tr><td align="center" valign="middle" >4a</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >Rd</td></tr><tr><td align="center" valign="middle" >4b</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >Rd</td></tr><tr><td align="center" valign="middle" >5a</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >Rd</td></tr><tr><td align="center" valign="middle" >5b</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >Rd</td></tr><tr><td align="center" valign="middle" >6a</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >NA</td></tr><tr><td align="center" valign="middle" >6b</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >NA</td></tr><tr><td align="center" valign="middle" >7a</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >NA</td></tr><tr><td align="center" valign="middle" >7b</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >NA</td></tr><tr><td align="center" valign="middle" >Penicillin</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >NA</td></tr><tr><td align="center" valign="middle" >Nystatin</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >-ve</td></tr></tbody></table></table-wrap><p>Rd: Reduced Growth; NA: Not Applicable.</p><p>3) It is clear that, a higher fluorine percentage present of the compounds, led to a more reduced growth of these microorganisms.</p><p>4) The most active fluorinated compounds 4a &amp; 4b, which have a similar activity of lamotrigine drug.</p></sec><sec id="s6"><title>6. Conclusion</title><p>Inspired by Lamotrigine drug constitutional and in a search of new high biocidal agents, fluorine substituted 1,2,4-triazines scaffolds have been synthesized via a simple methods with good yield. These compounds have been evaluated as antimicrobial agents as isomeric structural to lamotrigine, which showed a high activity, especially in the presence of -OMe groups, in addition to fluorine atoms. Further biological evaluation could screen the reactivity of few products containing thioxodihydropyrimidine-4,6(1H,5H)-dione(6) a moiety similar to thiobarbituric acid.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Bawazir, W.A. and Abdel-Rahman, R.M. (2018) Synthesis of New Fluorinated Amino-Heterocyclic Compounds Bearing 6-Aryl-5-Oxo-1,2,4Triazin-3-Yl Moiety as Antimicrobial Agents. International Journal of Organic Chemistry, 8, 349-358. https://doi.org/10.4236/ijoc.2018.84027</p></sec></body><back><ref-list><title>References</title><ref id="scirp.89019-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abdel-Rahman</surname><given-names> R.M. </given-names></name>,<etal>et al</etal>. (<year>1991</year>)<article-title>Synthesis and Antihuman Immune Virus Activity of Some New Fluorine Containing Substituted-3-Thioxo-1,2,4-Triazin-5-Ones</article-title><source> Farmaco (Societachimicaitaliana: 1989)</source><volume> 46</volume>,<fpage> 379</fpage>-<lpage>389</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.89019-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Abdel-Rahman, R.M., Makki, M.S., Ali, T.E. and Ibrahim, M.A. (2015) 1,2,4-Triazine Chemistry Part IV: Synthesis and Chemical Behavior of 3-Functionalized 5,6-Diphenyl-1,2,4-Triazines towards Some Nucleophilic and Electrophilic Reagents. Journal of Heterocyclic Chemistry, 52, 1595-1607. &lt;BR/&gt;https://doi.org/10.1002/jhet.2014</mixed-citation></ref><ref id="scirp.89019-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bakhotmah, D. andAbdel-Rahman, R. (2017) Synthesis and Structural Determination of Novel Fluorinated Steroidal Spiro (Pyrazolo[4, 3-e][1,2,4]Triazin-3’-yl) Derivatives as Affecting Enzymatic Agents. Letters in Organic Chemistry, 14, 134-140. &lt;BR/&gt;https://doi.org/10.2174/1570178614666161230143228</mixed-citation></ref><ref id="scirp.89019-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Abdel-Rahman, R.M., Angawi, R.F. and Al-Mehmadi, A.R. (2017) Synthesis and Biological Evaluation of Fluorine Substituted Pyrazolo[4, 3-e][1, 2, 4]Triazines as Purine Analogues. Journal of Saudi Chemical Society, 21, 495-503. &lt;BR/&gt;https://doi.org/10.1016/j.jscs.2016.11.004</mixed-citation></ref><ref id="scirp.89019-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Makki, M.S., Abdel-Rahman, R.M. and Khan, K.A. (2014) Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors. Journal of Chemistry, 2014, Article ID: 430573. &lt;BR/&gt;https://doi.org/10.1155/2014/430573</mixed-citation></ref><ref id="scirp.89019-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Makki, M., Bakhotmah, D.A., Abdel-Rahman, R.M. and Aqlan, F.M. (2018) New Route to Synthesize Fluorine Substituted Lamotrigine Drug Analogues as an Anti-Inflammatory Agent. Current Organic Synthesis, 15, 116-125. &lt;BR/&gt;https://doi.org/10.2174/1570179414666170509151123</mixed-citation></ref><ref id="scirp.89019-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Al-Romaizan, A.N., Makki, M.S.T., and Abdel-Rahman, R.M. () Synthesis of New Fluorine/Phosphorus Substituted 6-(2’-Amino Phenyl)-3-Thioxo-1,2,4-Triazin-5(2H, 4H) One and Their Related Alkylated Systems as Molluscicidal Agent as against the Snails Responsible for Bilharziasis Diseases. International Journal of Organic Chemistry, 4, 154-168. &lt;BR/&gt;https://doi.org/10.4236/ijoc.2014.42017</mixed-citation></ref><ref id="scirp.89019-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Makki, M.S.T., Abdel-Rahman, R.M. and Aqlan, F.M. (2015) Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents. International Journal of Organic Chemistry, 5, 200-211. &lt;BR/&gt;https://doi.org/10.4236/ijoc.2015.53020</mixed-citation></ref><ref id="scirp.89019-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Aqlan, F.M., Makki, M.S. and Abdel-Rahman, R.M. (2016) Synthesis, Spectroscopic Studies of Fluorinated Pyrimido-1,2,4-Triazines: Protective Effect against Some Plant Pathogenic Fungi. Journal of Heterocyclic Chemistry, 53, 1310-1317. &lt;BR/&gt;https://doi.org/10.1002/jhet.2386</mixed-citation></ref><ref id="scirp.89019-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Abdel-Rahman, R.M., Makki, M.S. and Al-Romaizan, A.N. (2014) Synthesis of Novel Fluorine Substituted Isolated and Fused Heterobicyclic Nitrogen Systems Bearing 6-(2’-Phosphorylanilido)-1,2,4-Triazin-5-One Moiety as Potential Inhibitor towards HIV-1 Activity. International Journal of Organic Chemistry, 4, 247-268. &lt;BR/&gt;https://doi.org/10.4236/ijoc.2014.44028</mixed-citation></ref><ref id="scirp.89019-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bolm, C., Kasyan, A. and Saladin, S. (2005) Synthesis of Novel Silylated 1,2,4-Tria-zin-5-Ones. Tetrahedron Letters, 46, 4049-4051. &lt;BR/&gt;https://doi.org/10.1016/j.tetlet.2005.04.021</mixed-citation></ref><ref id="scirp.89019-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Krauth, F., Dahse, H.M., Rüttinger, H.H. and Frohberg, P. (2010) Synthesis and Characterization of Novel 1,2,4-Triazine Derivatives with Antiproliferative Activity. Bioorganic &amp; Medicinal Chemistry, 18, 1816-1821. &lt;BR/&gt;https://doi.org/10.1016/j.bmc.2010.01.053</mixed-citation></ref><ref id="scirp.89019-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Liu, S.J., Yang, L., Jin, Z., Huang, E.F., Wan, D.C.C., Lin, H.Q. and Hua, C. (2009) Design, Synthesis, and Biological Evaluation of 7H-Thiazolo[3,2-b]-1,2,4-Triazin-7-One Derivatives as Novel Acetylcholinesterase Inhibitors. Arkivoc, 10, 333-348. &lt;BR/&gt;https://www.arkat-usa.org/get-file/29266/</mixed-citation></ref><ref id="scirp.89019-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Srinivasan, D., Nathan, S., Suresh, T. and Perumalsamy, P.L. (2001) Antimicrobial Activity of Certain Indian Medicinal Plants Used in Folkloric Medicine. Journal of Ethnopharmacology, 74, 217-220. &lt;BR/&gt;https://doi.org/10.1016/S0378-8741(00)00345-7</mixed-citation></ref></ref-list></back></article>